This Is MS Multiple Sclerosis Knowledge & Support Community

Posted: **Wed Jun 03, 2009 1:00 pm**

A small study found a significant effectivenes of pioglitazone (an approved diabetes typ-II drug) in protecting grey matter and a positive trend towards lower lesion load:

PubMed

--Frank

Posted: **Wed Jun 03, 2009 2:13 pm**

Thanks for posting the abstract Frank. As I mentioned in the pipeline thread, I'm still not putting this back on the list as I'm not convinced they are going to get the funding to do another trial with this. I hope to be proved spectacularly wrong, and soon.

This Is MS Multiple Sclerosis Knowledge & Support Community

Pilot-trial results of INF+pioglitazone

Pilot-trial results of INF+pioglitazone